Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-76fb5796d-25wd4 Total loading time: 0 Render date: 2024-04-27T18:39:58.463Z Has data issue: false hasContentIssue false

Screening: antenatal

from Medical topics

Published online by Cambridge University Press:  18 December 2014

By
Elizabeth Dormandy
Edited by
Susan Ayers ,
Andrew Baum ,
Chris McManus ,
Stanton Newman ,
Kenneth Wallston ,
John Weinman  and
Robert West
Elizabeth Dormandy
Affiliation:
King's College London
Susan Ayers
Affiliation:
University of Sussex
Andrew Baum
Affiliation:
University of Pittsburgh
Chris McManus
Affiliation:
St Mary's Hospital Medical School
Stanton Newman
Affiliation:
University College and Middlesex School of Medicine
Kenneth Wallston
Affiliation:
Vanderbilt University School of Nursing
John Weinman
Affiliation:
United Medical and Dental Schools of Guy's and St Thomas's
Robert West
Affiliation:
St George's Hospital Medical School, University of London
Get access

Summary

Antenatal screening is an important part of antenatal care as practised across the world (see ‘Antenatal care’). Pregnant women and their partners are routinely offered a range of screening tests to identify those who are at increased risk of a fetal anomaly including chromosomal abnormalities, structural abnormalities or haemoglobin disorders. Recently there has been a policy shift regarding the aim of antenatal screening, from reducing the incidence of conditions to facilitating informed choices for those offered screening (National Screening Committee, 2000) (see also ‘Screening: general issues’). This chapter describes the choices available for pregnant women and considers the extent to which informed choice is realized.

Screening choices

Women are offered screening tests which differ according to the condition screened for, the time in pregnancy, the detection rates and the safety of associated diagnostic tests. This section describes the choices available to women about antenatal screening.

Screening for chromosomal abnormalities

Down's syndrome (Trisomy 21) is the most common chromosomal abnormality screened for and affects about 1 in 700 live births in the UK. A variety of screening tests using different markers have been introduced during the last twenty years. These include ultrasound measurement of nuchal translucency and measurements in maternal serum of alpha-fetoprotein, pregnancy associated plasma protein, human chorionic gonadotrophin, oestriol or inhibin. Screening tests use different combinations of markers, with the name reflecting characteristics of the test such as the number of markers assessed (Double or Triple), the type of marker assessed (nuchal translucency), where it was developed (Bart's or Leeds) or the way the risk assessment was performed (Integrated).

Type
Chapter
Information
Cambridge Handbook of Psychology, Health and Medicine , pp. 854 - 857
Publisher: Cambridge University Press
Print publication year: 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Ahmed, S., Bekker, H., Hewison, J. & Kinsey, S. (2002). Thalassaemia carrier testing in Pakistani adults: Behaviour, knowledge and attitudes. Community Genetics, 5, 120–7.Google Scholar
Alderson, P. (2001). Prenatal screening, ethics and Down's syndrome: a literature review. Nursing Ethics, 8, 360–74.Google Scholar
Atkin, K. & Ahmad, W. (1998). Genetic screening and haemoglobinopathies: ethics, politics and practice. Social Science and Medicine, 46, 445–58.Google Scholar
Baillie, C., Smith, J., Hewison, J. & Mason, G. (2000). Ultrasound screening for chromosomal abnormality: women's reactions to false positive results. British Journal of Health Psychology, 5, 377–94.Google Scholar
Bekker, H., Thornton, J. G., Airey, C.et al. (1999). Informed decision making: an annotated bibliography and systematic review. Health Technology Assessment, 3, 1.Google Scholar
Bishop, A. J., Marteau, T. M., Armstrong, D.et al. (2004). Women and health care professionals' preferences for Down syndrome screening tests: a conjoint analysis study. British Journal of Obstetrics and Gynaecology, 111, 775–9.Google Scholar
Bricker, L., Garcia, J., Henderson, J.et al. (2000). Ultrasound screening in pregnancy: a systematic review of the clinical effectiveness, cost effectiveness and women's views. Health Technology Assessment, 4, 16.Google Scholar
Dormandy, E., Hooper, R., Michie, S. & Marteau, T. M. (2002). Informed choice to undergo prenatal screening: a comparison of two hospitals conducting testing either as part of a routine visit or requiring a separate visit. Journal of Medical Screening, 9, 109–14.Google Scholar
Dormandy, E. & Marteau, T. M. (2004). Uptake of an antenatal screening test: the role of healthcare professionals' attitudes towards the test. Prenatal Diagnosis, 24, 864–8.Google Scholar
Gilbert, R. E., Augood, C., Gupta, R.et al. (2001). Screening for Down's syndrome: effects, safety, and cost effectiveness of first and second trimester strategies. British Medical Journal, 323, 425.Google Scholar
Green, J. M., Hewison, J., Bekker, H., Bryant, L. & Cuckle, H. S. (2004). Psychosocial aspects of genetic screening of pregnant women and newborns: a systematic review. Health Technology Assessment, 8, 33.Google Scholar
Grimshaw, G., Szczepura, A., Hulton, M.et al. (2003). Evaluation of molecular tests for prenatal diagnosis of chromosome abnormalities. Health Technology Assessment, 7, 10.Google Scholar
Hall, S., Abramsky, L. & Marteau, T. M. (2003). Health professionals' reports of information given to parents following the prenatal diagnosis of sex chromosome anomalies and outcomes of pregnancies: a pilot study. Prenatal Diagnosis, 23, 535–8.Google Scholar
Kerr, A., Cunningham-Burley, S. & Amos, A. (1998). Eugenics and the new genetics in Britain: examining contemporary professionals' accounts. Science, Technology and Human Values, 23, 175–98.Google Scholar
Loeben, G., Marteau, T. M. & Wilfond, B. (1998). Mixed messages: presentation of information in cystic fibrosis screening pamphlets. American Journal of Human Genetics, 63, 1811–19.Google Scholar
Mansfield, C., Hopfer, S. & Marteau, T. M. (1999). Termination rates after prenatal diagnosis of Down syndrome, spina bifida, anencephaly and Turner and Klinefelter syndromes: a systematic literature review. Prenatal Diagnosis, 19, 808–12.Google Scholar
Marteau, T. M., Dormandy, E. & Michie, S. (2001). A measure of informed choice. Health Expectations, 4, 99–108.Google Scholar
Modell, B., Harris, R., Lane, B.et al. (2000). Informed choice in genetic screening for thalassaemia during pregnancy: audit from a national confidential inquiry. British Medical Journal, 320, 337–41.Google Scholar
Murray, J., Cuckle, H. S., Sehmi, I., Wilson, C. & Ellis, A. (2001). Quality of written information used in Down syndrome screening. Prenatal Diagnosis, 21, 138–42.Google Scholar
National Screening Committee. (2000). Second Report of the UK National Screening Committee, London: Department of Health.
Rowe, R., Garcia, J., Macfarlane, A. & Davidson, L. (2002). Improving communication between health professionals and women in maternity care: a structured review. Health Expectations, 5, 63–83.Google Scholar
Sadler, M. (1997). Serum screening for Down's syndrome: how much do health professionals know?British Journal of Obstetrics and Gynaecology, 104, 176–9.Google Scholar
Simpson, W., Johnstone, F. D., Boyd, F.et al. (1998). Uptake and acceptability of antenatal HIV testing: randomised controlled trial of different methods of offering the test. British Medical Journal, 316, 262–7.Google Scholar
Stapleton, H., Kirkham, M. & Thomas, G. (2002). Qualitative study of evidence based leaflets in maternity care. British Medical Journal, 324, 639.Google Scholar
Williams, C., Alderson, P. & Farsides, B. (2002). Too many choices? Hospital and community staff reflect on the future of prenatal screening. Social Science and Medicine, 55, 743–53.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×